Literature DB >> 21054665

Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit.

S Nseir1, C Blazejewski, R Lubret, F Wallet, R Courcol, A Durocher.   

Abstract

The objective of this prospective cohort study was to determine whether admission to an intensive care unit (ICU) room previously occupied by a patient with multidrug-resistant (MDR) Gram-negative bacilli (GNB) increases the risk of acquiring these bacteria by subsequent patients. All patients hospitalized for >48 h were eligible. Patients with MDR GNB at ICU admission were excluded. The MDR GNB were defined as MDR Pseudomonas aeruginosa, Acinetobacter baumannii and extended spectrum β-lactamase (ESBL) -producing GNB. All patients were hospitalized in single rooms. Cleaning of ICU rooms between two patients was performed using quaternary ammonium disinfectant. Risk factors for MDR P. aeruginosa, A. baumannii and ESBL-producing GNB were determined using univariate and multivariate analysis. Five hundred and eleven consecutive patients were included; ICU-acquired MDR P. aeruginosa was diagnosed in 82 (16%) patients, A. baumannii in 57 (11%) patients, and ESBL-producing GNB in 50 (9%) patients. Independent risk factors for ICU-acquired MDR P. aeruginosa were prior occupant with MDR P. aeruginosa (OR 2.3, 95% CI 1.2-4.3, p 0.012), surgery (OR 1.9, 95% CI 1.1-3.6, p 0.024), and prior piperacillin/tazobactam use (OR 1.2, 95% CI 1.1-1.3, p 0.040). Independent risk factors for ICU-acquired A. baumannii were prior occupant with A. baumannii (OR 4.2, 95% CI 2-8.8, p <0.001), and mechanical ventilation (OR 9.3, 95% CI 1.1-83, p 0.045). Independent risk factors for ICU-acquired ESBL-producing GNB were tracheostomy (OR 2.6, 95% CI 1.1-6.5, p 0.049), and sedation (OR 6.6, 95% CI 1.1-40, p 0.041). We conclude that admission to an ICU room previously occupied by a patient with MDR P. aeruginosa or A. baumannii is an independent risk factor for acquisition of these bacteria by subsequent room occupants. This relationship was not identified for ESBL-producing GNB.
© 2010 The Authors. Clinical Microbiology and Infection © 2010 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21054665     DOI: 10.1111/j.1469-0691.2010.03420.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  59 in total

1.  The road forward in the management of Acinetobacter infections in the ICU.

Authors:  Michael S Niederman; Marin H Kollef
Journal:  Intensive Care Med       Date:  2015-12       Impact factor: 17.440

2.  Carbapenem-Resistant Enterobacteriaceae: Laboratory Detection and Infection Control Practices.

Authors:  Eva-Brigitta Kruse; Ute Aurbach; Hilmar Wisplinghoff
Journal:  Curr Infect Dis Rep       Date:  2013-10-12       Impact factor: 3.725

Review 3.  The role of the healthcare environment in the spread of multidrug-resistant organisms: update on current best practices for containment.

Authors:  Roy F Chemaly; Sarah Simmons; Charles Dale; Shashank S Ghantoji; Maria Rodriguez; Julie Gubb; Julie Stachowiak; Mark Stibich
Journal:  Ther Adv Infect Dis       Date:  2014-06

4.  Colonization pressure as a risk factor of ICU-acquired multidrug resistant bacteria: a prospective observational study.

Authors:  J Masse; A Elkalioubie; C Blazejewski; G Ledoux; F Wallet; J Poissy; S Preau; S Nseir
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-20       Impact factor: 3.267

5.  Acquisition of carbapenem-resistant Acinetobacter baumannii in the intensive care unit: just a question of time?

Authors:  Ahmed Elkalioubie; Saad Nseir
Journal:  Ann Transl Med       Date:  2016-10

6.  Potentially resistant microorganisms in intubated patients with hospital-acquired pneumonia: the interaction of ecology, shock and risk factors.

Authors:  Ignacio Martin-Loeches; Maria Deja; Despoina Koulenti; George Dimopoulos; Brian Marsh; Antonio Torres; Michael S Niederman; Jordi Rello
Journal:  Intensive Care Med       Date:  2013-01-29       Impact factor: 17.440

7.  A Discrete Event Simulation Model of Patient Flow in a General Hospital Incorporating Infection Control Policy for Methicillin-Resistant Staphylococcus Aureus (MRSA) and Vancomycin-Resistant Enterococcus (VRE).

Authors:  Erica S Shenoy; Hang Lee; Erin E Ryan; Taige Hou; Rochelle P Walensky; Winston Ware; David C Hooper
Journal:  Med Decis Making       Date:  2017-06-29       Impact factor: 2.583

Review 8.  Controlling hospital-acquired infection: focus on the role of the environment and new technologies for decontamination.

Authors:  Stephanie J Dancer
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

9.  epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England.

Authors:  H P Loveday; J A Wilson; R J Pratt; M Golsorkhi; A Tingle; A Bak; J Browne; J Prieto; M Wilcox
Journal:  J Hosp Infect       Date:  2014-01       Impact factor: 3.926

10.  Touchless Technologies for Decontamination in the Hospital: a Review of Hydrogen Peroxide and UV Devices.

Authors:  Michelle Doll; Daniel J Morgan; Deverick Anderson; Gonzalo Bearman
Journal:  Curr Infect Dis Rep       Date:  2015-09       Impact factor: 3.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.